Madrigal Pharmaceuticals Stock Forecast - Simple Moving Average

MDGL Stock  USD 558.01  30.39  5.16%   
The Simple Moving Average forecasted value of Madrigal Pharmaceuticals on the next trading day is expected to be 558.01 with a mean absolute deviation of 13.01 and the sum of the absolute errors of 780.45. Madrigal Stock Forecast is based on your current time horizon. Although Madrigal Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Madrigal Pharmaceuticals' systematic risk associated with finding meaningful patterns of Madrigal Pharmaceuticals fundamentals over time.
As of now the rsi of Madrigal Pharmaceuticals' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Madrigal Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Madrigal Pharmaceuticals and does not consider all of the tangible or intangible factors available from Madrigal Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Madrigal Pharmaceuticals, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Madrigal Pharmaceuticals' stock price prediction:
EPS Estimate Next Quarter
(1.87)
EPS Estimate Current Year
(10.10)
EPS Estimate Next Year
2.4576
Wall Street Target Price
604.4
EPS Estimate Current Quarter
(1.99)
Using Madrigal Pharmaceuticals hype-based prediction, you can estimate the value of Madrigal Pharmaceuticals from the perspective of Madrigal Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Madrigal Pharmaceuticals using Madrigal Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Madrigal using crowd psychology based on the activity and movement of Madrigal Pharmaceuticals' stock price.

Madrigal Pharmaceuticals Short Interest

An investor who is long Madrigal Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Madrigal Pharmaceuticals and may potentially protect profits, hedge Madrigal Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA
393.3482
Short Percent
0.1891
Short Ratio
11.73
Shares Short Prior Month
3.7 M
50 Day MA
534.3634

Madrigal Pharmaceuticals Hype to Price Pattern

Investor biases related to Madrigal Pharmaceuticals' public news can be used to forecast risks associated with an investment in Madrigal. The trend in average sentiment can be used to explain how an investor holding Madrigal can time the market purely based on public headlines and social activities around Madrigal Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Madrigal Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Madrigal Pharmaceuticals.

Madrigal Pharmaceuticals Implied Volatility

    
  0.6  
Madrigal Pharmaceuticals' implied volatility exposes the market's sentiment of Madrigal Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Madrigal Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Madrigal Pharmaceuticals stock will not fluctuate a lot when Madrigal Pharmaceuticals' options are near their expiration.
The Simple Moving Average forecasted value of Madrigal Pharmaceuticals on the next trading day is expected to be 558.01 with a mean absolute deviation of 13.01 and the sum of the absolute errors of 780.45.

Madrigal Pharmaceuticals after-hype prediction price

    
  USD 557.77  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Madrigal Pharmaceuticals to cross-verify your projections.
For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.At this time, Madrigal Pharmaceuticals' Payables Turnover is quite stable compared to the past year. Fixed Asset Turnover is expected to rise to 37.08 this year, although the value of Inventory Turnover will most likely fall to 0.18. . Common Stock Shares Outstanding is expected to rise to about 25.7 M this year, although the value of Net Loss is projected to rise to (252.5 M).

Open Interest Against 2026-04-17 Madrigal Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Madrigal Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Madrigal Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Madrigal Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Madrigal Pharmaceuticals' open interest, investors have to compare it to Madrigal Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Madrigal Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Madrigal. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Madrigal Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Madrigal price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Madrigal using various technical indicators. When you analyze Madrigal charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
A two period moving average forecast for Madrigal Pharmaceuticals is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

Madrigal Pharmaceuticals Simple Moving Average Price Forecast For the 8th of January

Given 90 days horizon, the Simple Moving Average forecasted value of Madrigal Pharmaceuticals on the next trading day is expected to be 558.01 with a mean absolute deviation of 13.01, mean absolute percentage error of 321.70, and the sum of the absolute errors of 780.45.
Please note that although there have been many attempts to predict Madrigal Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Madrigal Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Madrigal Pharmaceuticals Stock Forecast Pattern

Backtest Madrigal PharmaceuticalsMadrigal Pharmaceuticals Price PredictionBuy or Sell Advice 

Madrigal Pharmaceuticals Forecasted Value

In the context of forecasting Madrigal Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Madrigal Pharmaceuticals' downside and upside margins for the forecasting period are 555.10 and 560.92, respectively. We have considered Madrigal Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
558.01
555.10
Downside
558.01
Expected Value
560.92
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Madrigal Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Madrigal Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria122.0463
BiasArithmetic mean of the errors -3.2211
MADMean absolute deviation13.0074
MAPEMean absolute percentage error0.0245
SAESum of the absolute errors780.445
The simple moving average model is conceptually a linear regression of the current value of Madrigal Pharmaceuticals price series against current and previous (unobserved) value of Madrigal Pharmaceuticals. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future

Predictive Modules for Madrigal Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Madrigal Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
554.86557.77560.68
Details
Intrinsic
Valuation
LowRealHigh
502.21616.52619.43
Details
15 Analysts
Consensus
LowTargetHigh
550.00604.40670.88
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-2.59-0.730.63
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Madrigal Pharmaceuticals. Your research has to be compared to or analyzed against Madrigal Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Madrigal Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Madrigal Pharmaceuticals.

Other Forecasting Options for Madrigal Pharmaceuticals

For every potential investor in Madrigal, whether a beginner or expert, Madrigal Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Madrigal Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Madrigal. Basic forecasting techniques help filter out the noise by identifying Madrigal Pharmaceuticals' price trends.

Madrigal Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Madrigal Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Madrigal Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Madrigal Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Madrigal Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Madrigal Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Madrigal Pharmaceuticals' current price.

Madrigal Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Madrigal Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Madrigal Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Madrigal Pharmaceuticals stock market strength indicators, traders can identify Madrigal Pharmaceuticals entry and exit signals to maximize returns.

Madrigal Pharmaceuticals Risk Indicators

The analysis of Madrigal Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Madrigal Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting madrigal stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Madrigal Pharmaceuticals is a strong investment it is important to analyze Madrigal Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Madrigal Pharmaceuticals' future performance. For an informed investment choice regarding Madrigal Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Madrigal Pharmaceuticals to cross-verify your projections.
For more information on how to buy Madrigal Stock please use our How to buy in Madrigal Stock guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Madrigal Pharmaceuticals. If investors know Madrigal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Madrigal Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(12.89)
Revenue Per Share
33.392
Quarterly Revenue Growth
3.62
Return On Assets
(0.16)
Return On Equity
(0.41)
The market value of Madrigal Pharmaceuticals is measured differently than its book value, which is the value of Madrigal that is recorded on the company's balance sheet. Investors also form their own opinion of Madrigal Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Madrigal Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Madrigal Pharmaceuticals' market value can be influenced by many factors that don't directly affect Madrigal Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Madrigal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Madrigal Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Madrigal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.